Vardhman Polytex allotted 55.25 lakh equity shares to promoter group entity Oswal Holding Private Limited after warrant conversion, bringing ₹5.20 crore into the company. The move increases paid-up capital, while 37.50 lakh warrants remain pending conversion.
Vardhman Polytex completes ₹5.20 crore warrant conversion
Vardhman Polytex allotted 55.25 lakh equity shares after conversion of promoter group warrants.
Oswal Holding Private Limited infused ₹5.20 crore through the share allotment at ₹12.55 per share.
Reader Takeaway: Promoter capital infusion supports funding, but remaining warrants may dilute equity later.
What just happened
Vardhman Polytex’s board approved the allotment of 55,25,000 equity shares to Oswal Holding Private Limited, a promoter group entity, on September 16, 2026.
The shares were issued after conversion of an equal number of warrants that were originally allotted to the promoter group on March 27, 2025.
The issue price was fixed at ₹12.55 per share, including a premium of ₹11.55 over the face value of ₹1. The company received the remaining 75% balance payment linked to the warrants, amounting to ₹5.20 crore.
Why this matters
The allotment increases Vardhman Polytex’s paid-up equity share capital to ₹50.46 crore, represented by 50,46,69,004 fully paid-up equity shares of ₹1 each.
The newly issued shares will rank equally with existing equity shares, meaning they will carry the same rights as current shareholders.
The transaction represents a capital infusion by the promoter group and does not involve an external investor fund raise.
What changes now
After the conversion, 37.50 lakh warrants remain outstanding. If these warrants are converted, the company’s equity base will increase further.
The remaining warrants carry an 18-month tenure from the date of original allotment. Warrants that are not exercised within the specified period will lapse, with the initial 25% subscription amount being forfeited as per the terms.
Risks to watch
Investors will need to monitor the conversion of the remaining warrants, as further exercise could affect the company’s share capital and ownership structure.
The current filing does not disclose any change in business operations, earnings outlook or financial performance following the allotment.
What to track next
The key points for shareholders are the utilisation of the infused capital and whether the remaining warrants are converted before expiry.